LigoCyte Buyout Beats Odds; Viral 'Load' on the Front End
It was an unlikely project, all the way around.
First, getting together a syndicate of venture capital investors to bet on vaccines – medicines typically given to healthy subjects, which makes possible toxicity an especially dicey proposition.
"You cannot have a safety problem, or you're dead," said Ivor Royston, founding managing partner of Forward Ventures, apparently intending no pun. "Why would a venture capitalist invest in something like that?"
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter